Prof. Dr. Frauke Alves
Co-Founder
-
Design of pre-clinical studies.
-
Academic development of (Dual)-Hybrid-NP technology and identification of novel medical application fields.
-
Consultation with international network, including pharma industry experts and clinicians of different medical fields.
-
Engages in discussions with clients and Advisory Board members.
-
Establishes new contact with external experts, and potential customers/ end-users.
-
Active involvement in operational activities of NDD in addition to her academic roles.
-
Presents results at scientific conferences, annual medical society meetings, to the general public, and through publications.
Biosketch
Frauke Alves is a medical doctor and cancer researcher, leading the interdisciplinary group “Translational Molecular Imaging” at the University Medical Center Göttingen and at the Max Planck Institute for Multidisciplinary Sciences, the largest institute in the Max Planck Society and unique in its multidisciplinary and translational approach. Through her long-standing collaboration with Prof. Claus Feldmann, she has extended her extensive experience with nanoparticle-based strategies, particularly by pre-clinically evaluating the jointly patented Hybrid- and Dual-Hybrid-NP. During her time as an oncologist in the hospital, she experienced many times the urgent need for better treatment, especially for pancreatic cancer. This experience has been a significant motivator for her work, driving her commitment to developing novel effective therapeutic concepts. Her expertise in cancer research, preclinical evaluation of nanotechnology, close collaboration with industrial partners, and dedication to improving patient outcomes make her an invaluable asset to our team.
Contact
Inspired by the high need for more effective therapies with fewer side effects in oncology.
Let’s connect to explore collaboration.